UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Constellium
CSTM
$4.02B
| $4.38M | ﹤0.01% |
266,300
-6,200
| -2% | -$115K |
|
1027
iShares Russell 1000 ETF
IWB
$49.8B
| $4.36M | ﹤0.01% |
37,992
-9,500
| -20% | -$1.06M |
|
|
DCT
1028
DELISTED
DCT Industrial Trust Inc.
DCT
| $4.32M | ﹤0.01% |
121,183
+10,998
| +10% | +$367K |
|
|
AOL
1029
DELISTED
AOL INC COMMON STOCK
AOL
| $4.3M | ﹤0.01% |
93,191
+35,700
| +62% | +$1.57M |
|
1030
ON Semiconductor
ON
$29.9B
| $4.29M | ﹤0.01% |
423,037
+14,762
| +4% | +$130K |
|
1031
Watsco Inc
WSO
$13.7B
| $4.28M | ﹤0.01% |
40,010
-437
| -1% | -$43.4K |
|
1032
COPT Defense Properties
CDP
$4.24B
| $4.28M | ﹤0.01% |
150,714
+15,400
| +11% | +$424K |
|
1033
RPM International
RPM
$14.9B
| $4.27M | ﹤0.01% |
84,187
+3,500
| +4% | +$163K |
|
1034
National Bank Holdings
NBHC
$1.93B
| $4.26M | ﹤0.01% |
219,600
-5,100
| -2% | -$98.2K |
|
1035
Grupo Cibest SA
CIB
$21.4B
| $4.26M | ﹤0.01% |
88,945
| – | – |
|
1036
Vanguard High Dividend Yield ETF
VYM
$82.5B
| $4.23M | ﹤0.01% |
61,544
+15,688
| +34% | +$1.06M |
|
|
AFSI
1037
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $4.21M | ﹤0.01% |
149,762
-31,400
| -17% | -$790K |
|
1038
Karyopharm Therapeutics
KPTI
$43.3M
| $4.2M | ﹤0.01% |
7,487
+6,947
| +1,286% | +$3.95M |
|
1039
Broadridge
BR
$18.9B
| $4.19M | ﹤0.01% |
90,793
-2,900
| -3% | -$127K |
|
|
PL
1040
DELISTED
PROTECTIVE LIFE CORP
PL
| $4.13M | ﹤0.01% |
59,346
| – | – |
|
|
BMS
1041
DELISTED
Bemis
BMS
| $4.1M | ﹤0.01% |
90,685
-124,743
| -58% | -$5.02M |
|
1042
iShares Russell 1000 Growth ETF
IWF
$127B
| $4.06M | ﹤0.01% |
169,996
+80,428
| +90% | +$1.88M |
|
1043
American Homes 4 Rent
AMH
$12.4B
| $4.04M | ﹤0.01% |
237,384
+19,500
| +9% | +$334K |
|
|
CRC
1044
DELISTED
California Resources Corporation
CRC
| $4.03M | ﹤0.01% |
+73,180
| New | +$4.41M |
|
|
ESL
1045
DELISTED
Esterline Technologies
ESL
| $3.98M | ﹤0.01% |
36,309
-7,595
| -17% | -$854K |
|
1046
Banner Corp
BANR
$2.4B
| $3.98M | ﹤0.01% |
92,563
+21,534
| +30% | +$892K |
|
1047
Nordson
NDSN
$17.3B
| $3.97M | ﹤0.01% |
50,987
-24,878
| -33% | -$1.89M |
|
1048
NCR Voyix
VYX
$1.31B
| $3.97M | ﹤0.01% |
222,101
-10,106
| -4% | -$178K |
|
|
BRLI
1049
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $3.95M | ﹤0.01% |
122,840
-9,098
| -7% | -$263K |
|
1050
Portland General Electric
POR
$5.79B
| $3.9M | ﹤0.01% |
103,027
+55,429
| +116% | +$2.01M |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.